Role of Medical Representatives in Competitive Market

References

[1] Acharya, A., & Hamid, A. B. A. (2024). A review on pharmaceutical marketing strategies from medical representatives in doctors’ prescribing decisions. International Journal of Research and Innovation in Social Science, 8(12), 1189–1199.

[2] Alkhateeb, F. M., Khanfar, N. M., & Clauson, K. A. (2009). Influence of pharmaceutical promotional tools on prescribing patterns. Health Marketing Quarterly, 26(2), 123–141.

[3] Bass, J. L., Marrone, C. M., & Klinger, C. (2009). Surveys of medical liaison practices across the pharmaceutical industry: A review. Drug Information Journal, 43(6), 675–681.

[4] Cook, H. E. (1997). Product management: Value, quality, cost, price, profit and organization. Springer.

[5] Ernst, H. (2002). Success factors of new product development: A review of the empirical literature. International Journal of Management Reviews, 4(1), 1–40.

[6] Gagnon, M. A., & Lexchin, J. (2008). The cost of pushing pills: Pharmaceutical promotion expenditures in the United States. PLoS Medicine, 5(1), 29–33.

[7] Kumar, A. S., & Kavitha, S. F. (2019). A role of medical representative in pharmaceutical industry. International Journal of Psychosocial Rehabilitation, 23(4), 1201–1208.

[8] Mansfield, P. R., Lexchin, J., Wen, L. S., Grandori, L., & McCoy, C. P. (2006). Educating health professionals about drug and device promotion. PLoS Medicine, 3(11), 185–192.

[9] Morgan, K. D., Domann, D. E., Collins, G. E., et al. (2000). History and evolution of field-based medical programs. Drug Information Journal, 34(3), 1049–1052.

[10] Murshid, M. A., & Mohaidin, Z. (2017). A systematic review of the influence of medical representatives and promotional tools on prescribing. International Journal of Pharmaceutical and Healthcare Marketing, 11(4), 361–394.

[11] Newman, D. J., & Cragg, G. M. (2016). Natural products as sources of new drugs. Journal of Natural Products, 79(3), 629–661.

[12] Salmasi, S., Ming, L. C., & Khan, T. M. (2016). Interaction and medical inducement between pharmaceutical representatives and physicians: A meta-synthesis. Journal of Pharmaceutical Policy and Practice, 9(37), 1–12.

[13] Setia, S., Ryan, N. J., Nair, P. S., Ching, E., & Subramaniam, K. (2018). Evolving role of pharmaceutical physicians in medical evidence and education. Advances in Medical Education and Practice, 9, 777–790.

[14] Spurling, G. K., Mansfield, P. R., Montgomery, B. D., et al. (2010). Information from pharmaceutical companies and the quality, quantity, and cost of physicians’ prescribing. PLoS Medicine, 7(10), e1000352.

[15] Undale, S., & Pande, M. S. (2016). Management of pharmaceutical sales representatives: A literature review. Journal of Chinese Pharmaceutical Sciences, 25(1), 73–78.

[16] Wazana, A. (2000). Physicians and the pharmaceutical industry: Is a gift ever just a gift? JAMA, 283(3), 373–380.

[17] WHO. (2017). Pharmaceutical market growth and healthcare systems. World Health Organization Report.

[18] Goulding, I. (1983). New product development: A literature review. European Journal of Marketing, 17(3), 3–30.

[19] Anandan, C. (2009). Product management. Tata McGraw-Hill Education.

[20] Guseo, R., & Mortarino, C. (2016). Modeling competition between two pharmaceutical drugs using innovation diffusion models. arXiv Preprint.

[21] Puente, J., de la Fuente, D., Lozano, J., & Gascon, F. (2012). Firm-specific characteristics of pharmaceutical generics and incentives to permanence. arXiv Preprint.

[22] Bonnefont, J., Courade, J. P., Alloui, A., & Eschalier, A. (2002). Antinociceptive mechanism of action of paracetamol. Drugs, 63(2), 1–4.

[23] Gorchels, L. (2000). The product manager’s handbook. McGraw-Hill.

[24] Marrone, C. M., Bass, J. L., & Klinger, C. J. (2007). Survey of medical liaison practices across the pharmaceutical industry. Drug Information Journal, 41(4), 457–470.

[25] Sreethy Mohan, V. S., & Rani, R. S. (2024). The mediating role of medical representatives. ShodhKosh: Journal of Visual and Performing Arts, 5(5), 1598–1603.

@article{1718058,
      author = {Devendra Kumar, Aman Kumar, Kuril Abhishek Sunilkumar, Alamgeer, Sangeeta Singh; Prashansa Rajvanshi},
      title = {Role of Medical Representatives in Competitive Market},
      journal = {Iconic Research And Engineering Journals},
      year = {2026},
      volume = {9},
      number = {11},
      pages = {2091-2101},
      issn = {2456-8880},
      url = {https://www.irejournals.com/formatedpaper/1718058.pdf},
      abstract = {Medical Representatives (MRs) are considered one of the most important pillars of the pharmaceutical industry. They act as a communication bridge between pharmaceutical companies and healthcare professionals by promoting medicines and healthcare products. In competitive pharmaceutical markets, medical representatives significantly influence prescription behavior, product awareness, sales growth, and brand positioning. The increasing competition among pharmaceutical companies has transformed the role of MRs from simple sales promoters to strategic relationship managers and scientific communicators. This review paper discusses the role, responsibilities, marketing strategies, challenges, ethical concerns, technological advancements, and future scope of medical representatives in competitive markets. The paper also highlights the impact of digital transformation and evolving healthcare systems on pharmaceutical marketing practices.},
      keywords = {Medical Representative, Pharmaceutical Marketing, Competitive Market, Drug Promotion, Prescription Behavior, Healthcare Professionals, Pharmaceutical Industry, Relationship Management, Digital Marketing.},
      month = {May},
      doi = {https://doi.org/10.64388/IREV9I11-1718058}
  }